Previous 10 | Next 10 |
New facility increases in vivo antibody discovery capacity Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the opening of its new Twist Bos...
Twist Bioscience ( NASDAQ: TWST ) is licensing a suite of its VHH antibody libraries to South Korea's Ildong Pharmaceutical to discover and develop antibodies for use in immuno-oncology therapies. Under the agreement, Ildong will license a suite of Twist’s ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical, today announced an agreement under which Ildong will license a suite of Twist VHH antibody l...
Biotechnology exchange traded funds look to build upon their winning streak on Friday as investors observed a double-digit performance jump across a handful of popular funds over the past week. Healthcare as a sector has been the best performing S&P segment of the market over the past wee...
Bear markets don't last forever. They also give forward-thinking investors plenty of opportunities to buy great stocks at a discount. We asked three Motley Fool contributors to identify stocks they think could double by 2025. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM...
The following slide deck was published by Twist Bioscience Corporation in conjunction with this event. For further details see: Twist Bioscience (TWST) Presents at the AGBT Conference 2022 - Slideshow
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Steffen Hellmold, senior vice president, business development for data storage, will present at th...
-- Twist MRD Rapid 500 Panel Enables Customers to Implement Fully Customizable Panels for $50 per Sample -- – Targets up to 500 Genomic Regions, Enables Unmatched Response Time – – MRD Testing Applications Include Cancer Therapy Response Monitoring and Disea...
Twist Bioscience (NASDAQ:TWST) on Tuesday announced the launch of its Human Methylome Panel, a product that can advance applications in cancer metastasis, human development and functional genetics. The company said its Twist Human Methylome Panel can also be used as a discovery tool to i...
Panel covers 84.2% of CpG islands New tool supports discovery of differentially methylated regions and epigenetic target identification for cancer metastasis and human development research Human methylome panel facilitates development of liquid biopsy panels Twist Bios...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...